Involvement of CD252 (CD134L) and IL-2 in the expression of cytotoxic proteins in bacterial- or viral-activated human T cells

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 7569-7579

  Walch, Michael ^a,c   Rampini, Silvana K ^a   Stoeckli, Isabelle ^a   Latinovic Golic, Sonja ^a   Dumrese, Claudia ^a   Sundstrom, Hanna ^a   Vogetseder, Alexander ^a   Marino, Joseph ^a   Glauser, Daniel L ^a   Van Den Broek, Maries ^a   Sander, Peter ^a,b   Groscurth, Peter ^a   Ziegler, Urs ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC FACTOR; GAMMA INTERFERON; GRANULYSIN; GRANZYME B; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; OX40 LIGAND; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; TNFSF4 PROTEIN, HUMAN;

ARTICLE; BACTERIUM CULTURE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; LISTERIA INNOCUA; LISTERIA MONOCYTOGENES; LYMPHOCYTE FUNCTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; UPREGULATION; VACCINIA VIRUS; VIRUS CULTURE; CELL CULTURE; CHLAMYDOPHILA; CYTOTOXICITY; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; LISTERIA; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOGENICITY; SECRETION; T LYMPHOCYTE;

CELLS, CULTURED; CHLAMYDOPHILA; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HERPESVIRUS 1, HUMAN; HUMANS; INTERLEUKIN-2; LISTERIA; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; OX40 LIGAND; PERFORIN; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; UP-REGULATION; VACCINIA VIRUS;

EID: 67649172590     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0800296     Document Type: Article

References (85)

1. Russell, J. H., and T. J. Ley. 2002. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20: 323-370.
2. Kaufmann, S. H. 1999. Cell-mediated immunity: dealing a direct blow to pathogens. Curr. Biol. 9: R97-R99.
3. Starnbach, M. N., M. J. Bevan, and M. F. Lampe. 1994. Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J. Immunol. 153: 5183-5189.
4. Williams, M. A., and M. J. Bevan. 2007. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25: 171-192.
5. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
6. Croft, M. 2003. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev. 14: 265-273.
7. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14: 233-258.
8. Carreno, B. M., and M. Collins. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20: 29-53.
9. Bertram, E. M., W. Dawicki, and T. H. Watts. 2004. Role of T cell costimulation in anti-viral immunity. Semin. Immunol. 16: 185-196.
10. + T cells. J. Immunol. 162: 3256-3262.
11. Gajewski, T. F., S. R. Schell, G. Nau, and F. W. Fitch. 1989. Regulation of T-cell activation: differences among T-cell subsets. Immunol. Rev. 111: 79-110.
12. Wong, P., and E. G. Pamer. 2004. Disparate in vitro and in vivo requirements for IL-2 during antigen-independent CD8 T cell expansion. J. Immunol. 172: 2171-2176. (Pubitemid 38182363)
13. Clayton, A., J. P. Mitchell, J. Court, M. D. Mason, and Z. Tabi. 2007. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 67: 7458-7466.
14. Lieberman, J. 2003. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 3: 361-370.
15. Ramshaw, I. A., A. J. Ramsay, G. Karupiah, M. S. Rolph, S. Mahalingam, and J. C. Ruby. 1997. Cytokines and immunity to viral infections. Immunol. Rev. 159: 119-135.
16. Podack, E. R., J. D. Young, and Z. A. Cohn. 1985. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc. Natl. Acad. Sci. USA 82: 8629-8633.
17. Martinvalet, D., D. M. Dykxhoorn, R. Ferrini, and J. Lieberman. 2008. Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death. Cell 133: 681-692.
18. Froelich, C. J., K. Orth, J. Turbov, P. Seth, R. Gottlieb, B. Babior, G. M. Shah, R. C. Bleackley, V. M. Dixit, and W. Hanna. 1996. New paradigm for lymphocyte granule-mediated cytotoxicity: target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J. Biol. Chem. 271: 29073-29079.
19. Pereira, R. A., M. M. Simon, and A. Simmons. 2000. Granzyme A, a noncytolytic component of CD8+ cell granules, restricts the spread of herpes simplex virus in the peripheral nervous systems of experimentally infected mice. J. Virol. 74: 1029-1032.
20. + T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322: 268-271.
21. Stenger, S., D. A. Hanson, R. Teitelbaum, P. Dewan, K. R. Niazi, C. J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melian, C. Bogdan, et al. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282: 121-125. (Pubitemid 28471143)
22. Walch, M., E. Eppler, C. Dumrese, H. Barman, P. Groscurth, and U. Ziegler. 2005. Uptake of granulysin via lipid rafts leads to lysis of intracellular Listeria innocua. J. Immunol. 174: 4220-4227.
23. Barman, H., M. Walch, S. Latinovic-Golic, C. Dumrese, M. Dolder, P. Groscurth, and U. Ziegler. 2006. Cholesterol in negatively charged lipid bilayers modulates the effect of the antimicrobial protein granulysin. J. Membr. Biol. 212: 29-39.
24. Ramamoorthy, A., S. Thennarasu, A. Tan, D. K. Lee, C. Clayberger, and A. M. Krensky. 2006. Cell selectivity correlates with membrane-specific interactions: a case study on the antimicrobial peptide G15 derived from granulysin. Biochim. Biophys. Acta 1758: 154-163.
25. Ghiasi, H., S. Cai, G. Perng, A. B. Nesburn, and S. L. Wechsler. 1999. Perforin pathway is essential for protection of mice against lethal ocular HSV-1 challenge but not corneal scarring. Virus Res. 65: 97-101.
26. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31-37.
27. Samuel, C. E. 1991. Antiviral actions of interferon: interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183: 1-11.
28. Mullbacher, A. 2003. Cell-mediated cytotoxicity in recovery from poxvirus infections. Rev. Med. Virol. 13: 223-232.
29. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254.
30. Gansert, J. L., V. Kiessler, M. Engele, F. Wittke, M. Rollinghoff, A. M. Krensky, S. A. Porcelli, R. L. Modlin, and S. Stenger. 2003. Human NKT cells express granulysin and exhibit antimycobacterial activity. J. Immunol. 170: 3154-3161.
31. Cooper, A. M., C. D'Souza, A. A. Frank, and I. M. Orme. 1997. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect. Immun. 65: 1317-1320.
32. Laochumroonvorapong, P., J. Wang, C. C. Liu, W. Ye, A. L. Moreira, K. B. Elkon, V. H. Freedman, and G. Kaplan. 1997. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect. Immun. 65: 127-132.
33. + T cell-mediated protection against an intracellular bacterium by perforindependent cytotoxicity. Eur. J. Immunol. 24: 3068-3072.
34. Rottenberg, M. E., A. C. Gigliotti Rothfuchs, D. Gigliotti, C. Svanholm, L. Bandholtz, and H. Wigzell. 1999. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J. Immunol. 162: 2829-2836.
35. Ehlers, S., C. Holscher, S. Scheu, C. Tertilt, T. Hehlgans, J. Suwinski, R. Endres, and K. Pfeffer. 2003. The lymphotoxin β receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes. J. Immunol. 170: 5210-5218.
36. Jouanguy, E., R. Doffinger, S. Dupuis, A. Pallier, F. Altare, and J. L. Casanova. 1999. IL-12 and IFN-γ in host defense against mycobacteria and salmonella in mice and men. Curr. Opin. Immunol. 11: 346-351.
37. Lampe, M. F., C. B. Wilson, M. J. Bevan, and M. N. Starnbach. 1998. Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect. Immun. 66: 5457-5461.
38. Roesler, J., B. Kofink, J. Wendisch, S. Heyden, D. Paul, W. Friedrich, J. L. Casanova, W. Leupold, M. Gahr, and A. Rosen-Wolff. 1999. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-γ-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp. Hematol. 27: 1368-1374.
39. Latinovic-Golic, S., M. Walch, H. Sundstrom, C. Dumrese, P. Groscurth, and U. Ziegler. 2007. Expression, processing and transcriptional regulation of granulysin in short-term activated human lymphocytes. BMC Immunol. 8: 9.
40. Filgueira, L., F. O. Nestle, M. Rittig, H. I. Joller, and P. Groscurth. 1996. Human dendritic cells phagocytose and process Borrelia burgdorferi. J. Immunol. 157: 2998-3005. (Pubitemid 126450058)
41. Sander, P., M. Rezwan, B. Walker, S. K. Rampini, R. M. Kroppenstedt, S. Ehlers, C. Keller, J. R. Keeble, M. Hagemeier, M. J. Colston, et al. 2004. Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 52: 1543-1552.
42. Master, S. S., S. K. Rampini, A. S. Davis, C. Keller, S. Ehlers, B. Springer, G. S. Timmins, P. Sander, and V. Deretic. 2008. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe 3: 224-232.
43. Dumrese, C., C. F. Maurus, D. Gygi, M. K. Schneider, M. Walch, P. Groscurth, and U. Ziegler. 2005. Chlamydia pneumoniae induces aponecrosis in human aortic smooth muscle cells. BMC Microbiol. 5: 2.
44. Glauser, D. L., R. Strasser, A. S. Laimbacher, O. Saydam, N. Clement, R. M. Linden, M. Ackermann, and C. Fraefel. 2007. Live covisualization of competing adeno-associated virus and herpes simplex virus type 1 DNA replication: molecular mechanisms of interaction. J. Virol. 81: 4732-4743.
45. van den Broek, M. F., U. Muller, S. Huang, M. Aguet, and R. M. Zinkernagel. 1995. Antiviral defense in mice lacking both α/β and γ interferon receptors. J. Virol. 69: 4792-4796.
46. + T lymphocytes. Histochem. Cell Biol. 123: 169-178.
47. Li, M., and Y. Zhang. 2006. Effect of antibody to CD134 on perforin-mediated cytolysis in human peripheral blood mononuclear cells. Hybridoma (Larchmt) 25: 145-153. (Pubitemid 43967700)
48. Perry, L. L., K. Feilzer, S. Hughes, and H. D. Caldwell. 1999. Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis. Infect. Immun. 67: 1379-1385.
49. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-γ- receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335: 1941-1949.
50. Ottenhoff, T. H., D. Kumararatne, and J. L. Casanova. 1998. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol. Today 19: 491-494.
51. + T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J. Immunol. 167: 2734-2742.
52. Ochoa, M. T., S. Stenger, P. A. Sieling, S. Thoma-Uszynski, S. Sabet, S. Cho, A. M. Krensky, M. Rollinghoff, E. Nunes Sarno, A. E. Burdick, et al. 2001. T-cell release of granulysin contributes to host defense in leprosy. Nat. Med. 7: 174-179.
53. Caccamo, N., S. Meraviglia, C. La Mendola, G. Guggino, F. Dieli, and A. Salerno. 2006. Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. J. Immunol. 177: 1780-1785. (Pubitemid 44092515)
54. Busiello, R., G. Fimiani, M. G. Miano, M. Arico, A. Santoro, M. V. Ursini, and C. Pignata. 2006. A91V perforin variation in healthy subjects and FHLH patients. Int. J. Immunogenet. 33: 123-125.
55. Katano, H., and J. I. Cohen. 2005. Perforin and lymphohistiocytic proliferative disorders. Br. J. Haematol. 128: 739-750.
56. Brastianos, P. K., J. W. Swanson, M. Torbenson, J. Sperati, and P. C. Karakousis. 2006. Tuberculosis-associated haemophagocytic syndrome. Lancet Infect. Dis. 6: 447-454.
57. + T cells by immature dendritic cells infected with live bacillus Calmette-Guérin mycobacteria. J. Leukocyte Biol. 72: 115-124.
58. Brandau, S., H. Suttmann, J. Riemensberger, U. Seitzer, J. Arnold, C. Durek, D. Jocham, H. D. Flad, and A. Bohle. 2000. Perforin-mediated lysis of tumor cells by Mycobacterium bovis bacillus Calmette-Guérin-activated killer cells. Clin. Cancer Res. 6: 3729-3738.
59. Kagi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25: 3256-3262.
60. Mullbacher, A., R. T. Hla, C. Museteanu, and M. M. Simon. 1999. Perforin is essential for control of ectromelia virus but not related poxviruses in mice. J. Virol. 73: 1665-1667.
61. Mullbacher, A., K. Ebnet, R. V. Blanden, R. T. Hla, T. Stehle, C. Museteanu, and M. M. Simon. 1996. Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. Proc. Natl. Acad. Sci. USA 93: 5783-5787.
62. + T-cell immunity to murine rotavirus in the absence of perforin, fas, and γ interferon. J. Virol. 71: 479-486.
63. Usherwood, E. J., J. W. Brooks, S. R. Sarawar, R. D. Cardin, W. D. Young, D. J. Allen, P. C. Doherty, and A. A. Nash. 1997. Immunological control of murine gammaherpesvirus infection is independent of perforin. J. Gen. Virol. 78: 2025-2030.
64. Liu, T., K. M. Khanna, B. N. Carriere, and R. L. Hendricks. 2001. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 75: 11178-11184.
65. Fehniger, T. A., S. F. Cai, X. Cao, A. J. Bredemeyer, R. M. Presti, A. R. French, and T. J. Ley. 2007. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26: 798-811.
66. Toossi, Z., H. Mayanja-Kizza, A. Kanost, K. Edmonds, M. McHugh, and C. Hirsch. 2004. Protective responses in tuberculosis: induction of genes for interferon-γ and cytotoxicity by Mycobacterium tuberculosis and during human tuberculosis. Scand. J. Immunol. 60: 299-306.
67. + T cells during primary activation. Int. Immunol. 14: 605-613.
68. Stuber, E., M. Neurath, D. Calderhead, H. P. Fell, and W. Strober. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2: 507-521.
69. Murata, K., N. Ishii, H. Takano, S. Miura, L. C. Ndhlovu, M. Nose, T. Noda, and K. Sugamura. 2000. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J. Exp. Med. 191: 365-374.
70. Kopf, M., C. Ruedl, N. Schmitz, A. Gallimore, K. Lefrang, B. Ecabert, B. Odermatt, and M. F. Bachmann. 1999. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus. Infect. Immun. 11: 699-708.
71. Gramaglia, I., A. D. Weinberg, M. Lemon, and M. Croft. 1998. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 161: 6510-6517. (Pubitemid 28562188)
72. Lepisto, A. J., M. Xu, H. Yagita, A. D. Weinberg, and R. L. Hendricks. 2007. Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis. J. Leukocyte Biol. 81: 766-774.
73. Fieschi, C., and J. L. Casanova. 2003. The role of interleukin-12 in human infectious diseases: only a faint signature. Eur. J. Immunol. 33: 1461-1464.
74. Dinarello, C. A. 1997. Interleukin-1. Cytokine Growth Factor Rev. 8: 253-265.
75. Smith, S. M., and H. M. Dockrell. 2000. Role of CD8 T cells in mycobacterial infections. Immunol. Cell Biol. 78: 325-333.
76. Brzoza, K. L., A. B. Rockel, and E. M. Hiltbold. 2004. Cytoplasmic entry of Listeria monocytogenes enhances dendritic cell maturation and T cell differentiation and function. J. Immunol. 173: 2641-2651.
77. Kanangat, S., J. Thomas, S. Gangappa, J. S. Babu, and B. T. Rouse. 1996. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression: implications in immunopathogenesis and protection. J. Immunol. 156: 1110-1116. (Pubitemid 26048105)
78. Gosselin, J., L. Flamand, M. D'Addario, J. Hiscott, I. Stefanescu, D. V. Ablashi, R. C. Gallo, and J. Menezes. 1992. Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis: a comparative study. J. Immunol. 149: 181-187.
79. Lusso, P. 2006. HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. J. Clin. Virol. 37(Suppl. 1): S4-S10.
80. Jarvis, M. A., J. A. Borton, A. M. Keech, J. Wong, W. J. Britt, B. E. Magun, and J. A. Nelson. 2006. Human cytomegalovirus attenuates interleukin-1β and tumor necrosis factor αproinflammatory signaling by inhibition of NF-κB activation. J. Virol. 80: 5588-5598.
81. + T cells. J. Immunol. 146: 1341-1347.
82. + T cells induces monocyte chemoattractant protein-1 in early listeriosis. J. Immunol. 159: 7-10.
83. Podack, E. R., H. Hengartner, and M. G. Lichtenheld. 1991. A central role of perforin in cytolysis? Annu. Rev. Immunol. 9: 129-157.
84. + T cells. J. Exp. Med. 171: 1269-1281.
85. Smyth, M. J., J. R. Ortaldo, W. Bere, H. Yagita, K. Okumura, and H. A. Young. 1990. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J. Immunol. 145: 1159-1166. (Pubitemid 20258718)